Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo

Background/Aims: Growing evidence suggests mitochondrial dysfunction (MtD) and the Nlrp3 inflammasome play critical roles in chronic kidney disease (CKD) progression. We previously reported that Aldosterone (Aldo)-induced renal injury in vitro is directly caused by mitochondrial reactive oxygen spec...

Full description

Bibliographic Details
Main Authors: Wei Ding, Tingyan Liu, Xiao Bi, Zhiling Zhang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2017-11-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/485287
_version_ 1811232022018916352
author Wei Ding
Tingyan Liu
Xiao Bi
Zhiling Zhang
author_facet Wei Ding
Tingyan Liu
Xiao Bi
Zhiling Zhang
author_sort Wei Ding
collection DOAJ
description Background/Aims: Growing evidence suggests mitochondrial dysfunction (MtD) and the Nlrp3 inflammasome play critical roles in chronic kidney disease (CKD) progression. We previously reported that Aldosterone (Aldo)-induced renal injury in vitro is directly caused by mitochondrial reactive oxygen species (mtROS)-mediated activation of the Nlrp3 inflammasome. Here we aimed to determine whether a mitochondria-targeted antioxidant (Mito-Tempo) could prevent Aldo-induced kidney damage in vivo. Methods: C57BL/6J mice were treated with Aldo and/or Mito-Tempo (or ethanol as a control) for 4 weeks. Renal injury was evaluated by Periodic Acid-Schiff reagent or Masson’s trichrome staining and electron microscopy. ROS were measured by DCFDA fluorescence and ELISA. MtD was determined by real-time PCR and electron microscopy. Activation of the Nlrp3 inflammasome and endoplasmic reticulum stress (ERS) was detected via western blot. Results: Compared with control mice, Aldo-infused mice showed impaired renal function, increased mtROS production and MtD, Nlrp3 inflammasome activation, and elevated ERS. We showed administration of Mito-Tempo significantly improved renal function and MtD, and reduced Nlrp3 inflammasome activation and ERS in vivo. Conclusion: Mitochondria-targeted antioxidants may attenuate Aldo-infused renal injury by inhibiting MtD, the Nlrp3 inflammasome, and ERS in vivo. Therefore, targeting mtROS might be an effective strategy for preventing CKD.
first_indexed 2024-04-12T10:55:01Z
format Article
id doaj.art-0015748a8bd74363b1507dc85010e978
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-04-12T10:55:01Z
publishDate 2017-11-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-0015748a8bd74363b1507dc85010e9782022-12-22T03:36:06ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782017-11-0144274175010.1159/000485287485287Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In VivoWei DingTingyan LiuXiao BiZhiling ZhangBackground/Aims: Growing evidence suggests mitochondrial dysfunction (MtD) and the Nlrp3 inflammasome play critical roles in chronic kidney disease (CKD) progression. We previously reported that Aldosterone (Aldo)-induced renal injury in vitro is directly caused by mitochondrial reactive oxygen species (mtROS)-mediated activation of the Nlrp3 inflammasome. Here we aimed to determine whether a mitochondria-targeted antioxidant (Mito-Tempo) could prevent Aldo-induced kidney damage in vivo. Methods: C57BL/6J mice were treated with Aldo and/or Mito-Tempo (or ethanol as a control) for 4 weeks. Renal injury was evaluated by Periodic Acid-Schiff reagent or Masson’s trichrome staining and electron microscopy. ROS were measured by DCFDA fluorescence and ELISA. MtD was determined by real-time PCR and electron microscopy. Activation of the Nlrp3 inflammasome and endoplasmic reticulum stress (ERS) was detected via western blot. Results: Compared with control mice, Aldo-infused mice showed impaired renal function, increased mtROS production and MtD, Nlrp3 inflammasome activation, and elevated ERS. We showed administration of Mito-Tempo significantly improved renal function and MtD, and reduced Nlrp3 inflammasome activation and ERS in vivo. Conclusion: Mitochondria-targeted antioxidants may attenuate Aldo-infused renal injury by inhibiting MtD, the Nlrp3 inflammasome, and ERS in vivo. Therefore, targeting mtROS might be an effective strategy for preventing CKD.https://www.karger.com/Article/FullText/485287AldosteroneMitochondrial dysfunctionNlrp3 inflammasomeEndoplasmic reticulum stressMito-Tempo
spellingShingle Wei Ding
Tingyan Liu
Xiao Bi
Zhiling Zhang
Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo
Cellular Physiology and Biochemistry
Aldosterone
Mitochondrial dysfunction
Nlrp3 inflammasome
Endoplasmic reticulum stress
Mito-Tempo
title Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo
title_full Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo
title_fullStr Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo
title_full_unstemmed Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo
title_short Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo
title_sort mitochondria targeted antioxidant mito tempo protects against aldosterone induced renal injury in vivo
topic Aldosterone
Mitochondrial dysfunction
Nlrp3 inflammasome
Endoplasmic reticulum stress
Mito-Tempo
url https://www.karger.com/Article/FullText/485287
work_keys_str_mv AT weiding mitochondriatargetedantioxidantmitotempoprotectsagainstaldosteroneinducedrenalinjuryinvivo
AT tingyanliu mitochondriatargetedantioxidantmitotempoprotectsagainstaldosteroneinducedrenalinjuryinvivo
AT xiaobi mitochondriatargetedantioxidantmitotempoprotectsagainstaldosteroneinducedrenalinjuryinvivo
AT zhilingzhang mitochondriatargetedantioxidantmitotempoprotectsagainstaldosteroneinducedrenalinjuryinvivo